Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Levitt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|December 26, 2003
Pure red-cell aplasia secondary to antierythropoietin antibodiesSteven S Guest, Lee Levitt
The New England Journal of Medicine|May 25, 2002
Hyperammonemic encephalopathy in multiple myelomaLawrence Kwan, Clifford Wang, Lee Levitt
The New England Journal of Medicine|July 28, 2010
JAK2 mutations and coronary ischemiaKusum Lata, Nalini Madiraju, Lee Levitt
The New England Journal of Medicine|February 20, 2004
Diffuse small-bowel myelomatosisRebecca Weintraub, Sharmila Pramanik, Lee Levitt
The New England Journal of Medicine|January 27, 2007
Sentinel-node biopsy in melanomaMatthew H Kanzler, Lee Levitt, Albert Lin
The New England Journal of Medicine|April 27, 2012
Case 2-2012: Dyspnea and rapidly progressive respiratory failureJason J Lee, Lee Levitt, Albert Y Lin
American Journal of Clinical Oncology|April 1, 2008
Phase II study of imatinib in unresectable hepatocellular carcinomaAlbert Y Lin, George A Fisher, Samuel So, et al.
Cancer|November 27, 2004
Phase II study of thalidomide in patients with unresectable hepatocellular carcinomaAlbert Y Lin, Nathalie Brophy, George A Fisher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|December 26, 2003
Pure red-cell aplasia secondary to antierythropoietin antibodiesSteven S Guest, Lee Levitt
The New England Journal of Medicine|May 25, 2002
Hyperammonemic encephalopathy in multiple myelomaLawrence Kwan, Clifford Wang, Lee Levitt
The New England Journal of Medicine|July 28, 2010
JAK2 mutations and coronary ischemiaKusum Lata, Nalini Madiraju, Lee Levitt
The New England Journal of Medicine|February 20, 2004
Diffuse small-bowel myelomatosisRebecca Weintraub, Sharmila Pramanik, Lee Levitt
The New England Journal of Medicine|January 27, 2007
Sentinel-node biopsy in melanomaMatthew H Kanzler, Lee Levitt, Albert Lin
The New England Journal of Medicine|April 27, 2012
Case 2-2012: Dyspnea and rapidly progressive respiratory failureJason J Lee, Lee Levitt, Albert Y Lin
American Journal of Clinical Oncology|April 1, 2008
Phase II study of imatinib in unresectable hepatocellular carcinomaAlbert Y Lin, George A Fisher, Samuel So, et al.
Cancer|November 27, 2004
Phase II study of thalidomide in patients with unresectable hepatocellular carcinomaAlbert Y Lin, Nathalie Brophy, George A Fisher, et al.
Pageof 1